ERBB2 and breast cancer: Luminal B ER+ BC represent about 20–30% and tend to be higher grade and have worse prognosis than luminal A, and they show lower expression of ER-related genes, however, show higher expression of cell proliferation-related genes and a variable expression of HER2.